Final Evidence Report and Meeting Summary
New England CEPAC

PDF cover

Type 2 Diabetes: Final Report

This report examines the comparative effectiveness and value of several management options for type 2 diabetes, including metformin, sulfonylureas, GLP-1 receptor agonists, DPP-4 inhibitors, and different types of insulin. It includes a systematic review of the published evidence, an economic analysis that examines cost-effectiveness and budget impact of the two interventions, and recommendations to guide policy and practice.


View All Materials on this Topic or Go Back to View More Materials